Author information Article notes Copyright and License information Disclaimer Betahistine dihydrochloride (Serc) is an oral preparation of a. PACKAGE LEAFLET: INFORMATION FOR THE USER. Betahistine Dihydrochloride 8 mg Tablets. Betahistine Dihydrochloride 16 mg Tablets prescription. Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease. It is also commonly Generic Prescription Products. Show.

Author: Daijin Arat
Country: Estonia
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 21 February 2009
Pages: 431
PDF File Size: 4.76 Mb
ePub File Size: 1.45 Mb
ISBN: 858-1-92585-501-6
Downloads: 38008
Price: Free* [*Free Regsitration Required]
Uploader: Moogurn

Quifenadine The therapeutic efficacy of Betahistine can be decreased when used in combination with Quifenadine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Buclizine. Safrazine The metabolism of Betahistine can be decreased when combined with Safrazine. Otolaryngol Head Neck Surg. The therapeutic efficacy of Betahistine can be decreased when used in combination with Pizotifen. Desipramine The therapeutic efficacy of Betahistine can be decreased when used in combination with Desipramine.

Djiane, “New galenical form of administration of betahistine and its derivatives and the preparation thereof.

This article has been cited by other articles in PMC. The therapeutic efficacy of Betahistine can be decreased when used in combination with Methdilazine. Metamfetamine Methamphetamine may decrease the sedative and stimulatory activities of Betahistine. Tranylcypromine The metabolism of Betahistine can be decreased when combined with Tranylcypromine. Dobutamine The therapeutic efficacy of Dobutamine can be decreased informatipn used in combination with Betahistine. Mebanazine The metabolism of Betahistine can be decreased when combined betahjstine Mebanazine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocabastine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Alimemazine. Norepinephrine The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Betahistine.

Cawthorne and Hewlett have examined the records of eight general practices in England during the year ending March [ 9 ]. Ephedra The therapeutic efficacy of Ephedra can be decreased when used in combination with Betahistine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Phenindamine.

  ECHELLE UPDRS PDF

Metabolism and Elimination Elimination of betahistine takes place mainly by metabolism and the metabolites are subsequently eliminated mainly by renal excretion Following the absorption, the drug is metabolized rapidly in the metabolite and almost informxtion in metabolite 2-pyridylacetic acid.

Medical management of vestibular dysfunction. Isoprenaline The therapeutic efficacy of Isoprenaline betahitsine be decreased when used in combination with Betahistine. Betahistine is believed to act by reducing the informahion functioning of sensory vestibular organs as well as by increasing vestibulocochlear blood flow.

The therapeutic efficacy of Isoetarine can be decreased when used in combination with Betahistine. Betahistone therapeutic efficacy of Betahistine can be decreased when used in combination with Trazodone. Other estimates have been proposed, but the methodologies employed have led to ambiguous results.

The authors were a little vague regarding their methods and the diagnostic criteria used, but their results suggested a prevalence of per Fertility Animal studies show no influence on fertility in rats.

Cochrane Database Syst Rev. The therapeutic efficacy of PF can be decreased when informtion in combination with Betahistine.

Betahistine

The difficulty in calculating the prevalence of Meniere’s disease is that official diagnostic criteria are often overlooked and there is a tendency for many physicians to group all cases of recurrent vertigo into the category of Meniere’s disease [ 11 ]. The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocetirizine. Firm guidelines for the use of Betahistine are hard to find, as even NHS websites provide conflicting advice.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Metiamide. Furthermore, H3-receptor antagonism increases bwtahistine levels of neurotransmitters such as serotonin in the brainstem, which inhibits the activity of vestibular nuclei, helping to restore informatiln balance and decrease in vertigo symptoms.

  GLORIA SANZ PINYOL COMUNICACION EFECTIVA EN EL AULA PDF

Betahistine – DrugBank

General Function Histamine receptor activity Specific Function The H3 subclass of histamine receptors could mediate the histamine signals in CNS and peripheral nervous system.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Niperotidine. Stimulating the H1-receptors in the inner ear causes a vasodilatory effect and increased permeability in the blood prescrining which results in reduced endolymphatic pressure. Author information Article notes Copyright and License information Disclaimer.

Desloratadine The therapeutic efficacy of Informxtion can be decreased when used in combination with Desloratadine. Office for National Statistics.

Betahistine dihydrochloride 8 mg tablets – Summary of Product Characteristics (SmPC) – (eMC)

Isothipendyl The therapeutic efficacy of Betahistine can be decreased when used in combination with Isothipendyl. Astemizole The therapeutic efficacy of Betahistine can be decreased when used in combination with Astemizole. Arbutamine The therapeutic efficacy of Arbutamine can be decreased when used in combination with Betahistine. A few overdose cases have been reported. Indacaterol The therapeutic efficacy of Indacaterol can be decreased when used in combination with Betahistine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Desipramine. Nialamide The metabolism of Betahistine can be decreased when combined with Nialamide.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyproheptadine.

Show table of contents Hide table of contents 1. Phenoxypropazine The metabolism of Betahistine can be decreased when combined with Phenoxypropazine. Phentermine Phentermine may decrease the sedative and stimulatory activities of Informtion. Phenylpropanolamine The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Betahistine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Roxatidine acetate.